This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Unmuddying the Waters

Sanford M. Goldstein, MD; Bruce W. Wintroub, MD; Peter M. Elias, MD; Kirk D. Wuepper, MD

Arch Dermatol. 1987;123(9):1153-1156.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Toxic epidermal necrolysis (TEN), or Lyell's syndrome,¹ holds a unique place among dermatologic diseases for its frightening, rapidly progressive, and all too often tragic outcome. Our lack of understanding of the pathogenesis of this disease, coupled with its infrequency and the lack of objective laboratory criteria for its diagnosis, have created considerable confusion and controversy over its nosology.

Still, we have made some important progress in differentiating TEN from staphylococcal scalded skin syndrome (SSSS),^2,3 in providing supportive care,^4,5 and in determining the prognosis of cases.^6,7 Yet investigators both at the bedside and in the laboratory have been impeded by a disease that seemingly can have varied presentations and an unpredictable course, and can be triggered by a panoply of causes; eg, drug,⁸ infectious,⁹ and immunologic factors.^10,11 Although there is general agreement that TEN is characterized by widespread blistering of the skin with a . . . [Full Text PDF of this Article]

Author Affiliations
Dermatology Service, 190 Veterans Administration Medical Center Department of Dermatology University of California, San Francisco San Francisco, CA 94121; Oregon Health Science University Portland, OR 97201

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?